Clear Search
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 24, 2022

In the news: Addressing the national blood shortage, Labor Department withdraws vaccine mandate, FDA decision on monoclonal antibodies and more.

Publications & Newsletters
·
16 Min Read

Laura Hoffman, JD, on protecting patients' vaccination data [Podcast]

The AMA is leading the fight against the COVID-19 pandemic. Listen to podcast updates on how the AMA is fighting COVID-19 by discussing how to prioritize and protect patients' vaccination data.

series
HIPAA
AMA Update Podcast
·
16 Min Read

Laura Hoffman, JD, on protecting patients' vaccination data

The AMA is leading the fight against the COVID-19 pandemic. See video updates on how the AMA is fighting COVID-19 by discussing how to prioritize and protect patients' vaccination data.

series
HIPAA
AMA Update
Coronavirus cell under magnifying glass
·
10 Min Read

What doctors wish patients knew about breakthrough COVID infections

The rapid spread of the SARS-CoV-2 Omicron variant has led to more fully vaccinated patients acquiring COVID-19. Learn why that happens and how boosters help.

series
Infectious Diseases
What Doctors Wish Patients Knew™
Hand holding a sticker
·
4 Min Read

How 2 health systems succeeded with vaccine requirements

Some big hospital names have pulled back on such efforts. Learn from other leaders who have pushed ahead to protect their workers and communities.

series
Infectious Diseases
Health System Spotlight
Smiling person holding up a sleeve to show a bandaged arm from a vaccine
·
4 Min Read

How CPT codes help track COVID-19 vaccine life cycle

The AMA CPT Editorial Panel has moved faster than ever to create codes during the pandemic. Find out why that streamlined effort is so crucial.

CPT®
4 Min Read

COVID-19 vaccines: Pfizer-BioNTech

Pfizer-BioNTech COVID-19 vaccine is the first COVID-19 vaccine and first mRNA to receive full FDA approval and is being marketed as Comirnaty.

Infectious Diseases
3 Min Read

COVID-19 vaccines: Moderna

Moderna received emergency use authorization (EUA) by the FDA for their mRNA vaccine for COVID-19 on Dec. 20, 2020.

Infectious Diseases
3 Min Read

COVID-19 vaccines: Janssen/Johnson & Johnson

The Johnson & Johnson/Janssen (J&J) SARS-CoV-2 viral vector vaccine is the third COVID-19 vaccine authorized by FDA to help prevent more severe COVID-19 outcomes, including hospitalizations and death.

Infectious Diseases